ArticleAmerican journal of respiratory and critical care medicine2019
Tumor-derived Autoantibodies Identify Malignant Pulmonary Nodules.
Open access · greenAbstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.
- EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation.Health technology assessment (Winchester, England) · 2022Pooled it
- T-cell Receptor Profiling of Blood to Detect Lung Cancer.Cancer immunology research · 2025Article
- Application of liquid biopsy in differentiating lung cancer from benign pulmonary nodules (Review).International journal of molecular medicine · 2025Review
- The role of B cell immunity in lung adenocarcinoma.Genes and immunity · 2025Review
- Validation of a High-Specificity Blood Autoantibody Test to Detect Lung Cancer in Pulmonary Nodules.CHEST pulmonary · 2025Article
- Five autoantibodies identified from immune complexes as breast cancer biomarkers.Frontiers in immunology · 2025Article
- Precise diagnosis and prognosis assessment of malignant lung nodules: a narrative review.Journal of thoracic disease · 2024Review
- Breaking tolerance: autoantibodies can target protein posttranslational modifications.Current opinion in biotechnology · 2024Review
- Autoantibody repertoire profiling in tissue and blood identifies colorectal cancer-specific biomarkers.Cancer science · 2024Article
- Review
- Discovery of potential biomarkers for lung cancer classification based on human proteome microarrays using Stochastic Gradient Boosting approach.Journal of cancer research and clinical oncology · 2023Article
- Multi-Omic Biomarkers Improve Indeterminate Pulmonary Nodule Malignancy Risk Assessment.Cancers · 2023Article
- BACH1-induced ferroptosis drives lymphatic metastasis by repressing the biosynthesis of monounsaturated fatty acids.Cell death & disease · 2023Article
- Posttranslational modifications induce autoantibodies with risk prediction capability in patients with small cell lung cancer.Science translational medicine · 2023Article
- Prostate cancer autoantibodies - applications in diagnosis, prognosis, monitoring disease progression and immunotherapy.American journal of clinical and experimental urology · 2023Review
- Integrative Serum Metabolic Fingerprints Based Multi-Modal Platforms for Lung Adenocarcinoma Early Detection and Pulmonary Nodule Classification.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022Article
- Circulating mitochondrial DNA as a biomarker for lung cancer screening.Translational lung cancer research · 2022Article
- Integrated Biomarkers for the Management of Indeterminate Pulmonary Nodules.American journal of respiratory and critical care medicine · 2021Article
- The promises and challenges of early non-small cell lung cancer detection: patient perceptions, low-dose CT screening, bronchoscopy and biomarkers.Molecular oncology · 2021Review
- Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell Carcinoma.The Journal of investigative dermatology · 2021Review
Corrections and comments
- Commented on by
Authors and funding
14 authors at 7 institutions in 5 countries.
Kristin J Lastwika1 Translational Research Program, Public Health Sciences.
Julia Kargl2 Human Biology Division.
Yuzheng Zhang5 Program in Biostatistics and Biomathematics, Division of Public Health Sciences, and.
Xiaodong Zhu2 Human Biology Division.
Edward Lo1 Translational Research Program, Public Health Sciences.
David Shelley1 Translational Research Program, Public Health Sciences.
Jon J Ladd1 Translational Research Program, Public Health Sciences.
Wei Wu6 Department of Radiology, University of Washington, Seattle, Washington; and.
Paul Kinahan6 Department of Radiology, University of Washington, Seattle, Washington; and.
Sudhakar N J Pipavath6 Department of Radiology, University of Washington, Seattle, Washington; and.
Timothy W Randolph5 Program in Biostatistics and Biomathematics, Division of Public Health Sciences, and.
Melissa Shipley3 Clinical Research Division.
Paul D Lampe1 Translational Research Program, Public Health Sciences.
A McGarry Houghton2 Human Biology Division.
Centro Regional de Derechos Humanos y Justicia de Género, Corporación Humanas · CLBiomathematics and Statistics Scotland · GBUniversity of Washington · USCenter for Clinical Research (United States) · USFred Hutch Cancer Center · USMedical University of Graz · ATTongji University · CN
Funding
Project 4: Risk stratification for pulmonary nodules detected by CT imaging using plasma and imaging biomarkersP50CA228944 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI A McGarry Houghton · 2019 to 2026
$19.6MHybrid Plasma Markers that Complement CT Imaging for Early Lung Cancer DetectionU01CA186157 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HOUGHTON, A MCGARRY, LAMPE, PAUL D. · 2015 to 2019
$2.5MProteomic, Glycomic and Autoantibody Lung Cancer Biomarker ValidationU01CA185097 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HOUGHTON, A MCGARRY, LAMPE, PAUL D. · 2014 to 2016
$1.1MHybrid Glycoproteomic and Autoantibody Biomarkers for Lung Cancer Early DetectionF32CA200265 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LASTWIKA, KRISTIN J · 2016 to 2019
$183kNCI NIH HHS F32 CA200265NCI NIH HHS P50 CA228944NCI NIH HHS U01 CA185097NCI NIH HHS U01 CA186157
Abstract
PubMed holds no abstract for this paper.
Indexed as
AgedAutoantibodiesBiomarkers, TumorCarcinoma, Non-Small-Cell LungDiagnosis, DifferentialEarly Detection of CancerFemaleHumansLung NeoplasmsMaleMiddle AgedMultiple Pulmonary NodulesSensitivity and SpecificityTomography, X-Ray ComputedAutoantibodiesBiomarkers, TumorB cellscomputed tomography imagingearly detectionindeterminate pulmonary noduleslung cancer
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.